Brief: Diasorin Q3 Adj. EBITDA At EUR 94 Mln
Nov 5 (Reuters) - DiaSorin SpA DIAS.MI :
* Q3 NET PROFIT EUR 45 MILLION
* Q3 ADJUSTED EBITDA EUR 94 MILLION
* Q3 REVENUE EUR 287 MILLION
* SEES FOR 2024 EX-COVID REVENUES ABOUT +7% (COVID REVENUES
ABOUT
EUR 30 MILLION
* CONFIRMS FOR 2024 ADJUSTED EBITDA MARGIN AROUND 33%
Further company coverage: DIAS.MI
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest